Encompass Health Co. (NYSE:EHC) Shares Sold by Thrivent Financial for Lutherans

Posted by on May 14th, 2023

Thrivent Financial for Lutherans reduced its stake in Encompass Health Co. (NYSE:EHC – Get Rating) by 26.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,923 shares of the company’s stock after selling 35,572 shares during the period. Thrivent Financial for Lutherans owned approximately 0.10% of Encompass Health worth $5,797,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Wipfli Financial Advisors LLC acquired a new stake in Encompass Health in the 3rd quarter valued at $25,000. CWM LLC boosted its position in Encompass Health by 67.6% in the 3rd quarter. CWM LLC now owns 625 shares of the company’s stock valued at $28,000 after buying an additional 252 shares during the last quarter. U.S. Capital Wealth Advisors LLC purchased a new position in Encompass Health in the 4th quarter valued at about $30,000. Worth Asset Management LLC purchased a new position in Encompass Health in the 1st quarter valued at about $35,000. Finally, Eagle Bay Advisors LLC boosted its position in Encompass Health by 128.8% in the 4th quarter. Eagle Bay Advisors LLC now owns 1,547 shares of the company’s stock valued at $93,000 after buying an additional 871 shares during the last quarter. 96.14% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Trading Down 0.9 %

Shares of NYSE:EHC opened at $61.30 on Friday. The stock has a market capitalization of $6.14 billion, a PE ratio of 22.70, a P/E/G ratio of 1.70 and a beta of 1.06. Encompass Health Co. has a 1 year low of $44.33 and a 1 year high of $66.54. The firm has a fifty day moving average price of $58.40 and a 200 day moving average price of $58.54. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 1.41.

Encompass Health (NYSE:EHC – Get Rating) last released its earnings results on Friday, April 28th. The company reported $0.88 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.18. The firm had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.14 billion. Encompass Health had a net margin of 5.75% and a return on equity of 16.80%. The business’s revenue was down 13.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.97 EPS. Analysts expect that Encompass Health Co. will post 3.14 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 17th. Stockholders of record on Monday, July 3rd will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Friday, June 30th. Encompass Health’s dividend payout ratio is currently 22.22%.

Analyst Upgrades and Downgrades

EHC has been the topic of several research analyst reports. Stephens reaffirmed an “overweight” rating and set a $70.00 price target on shares of Encompass Health in a research report on Wednesday, February 8th. Mizuho raised their price objective on shares of Encompass Health from $69.00 to $74.00 in a research note on Monday, May 1st. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Monday, May 1st. Bank of America raised their price objective on shares of Encompass Health from $69.00 to $74.00 in a research note on Friday, April 28th. Finally, UBS Group raised their price objective on shares of Encompass Health from $68.00 to $73.00 in a research note on Wednesday, February 8th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and an average target price of $70.91.

About Encompass Health

(Get Rating)

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

See Also

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.